Viking Therapeutics (VKTX) Market Capitalization (2015 - 2026)
Viking Therapeutics' Market Capitalization came in at $4.55 billion for Q2 2026, up 52.9% from $2.98 billion a year earlier and up 20.7% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Market Capitalization (2015 - 2026) Analysis & Trends
For FY2025, Viking Therapeutics' Market Capitalization was $4.04 billion, down 10.1% from FY2024.
- Market Capitalization carries a five-year compound annual growth rate of 57.8% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $4.49 billion in FY2024 (+141.0%), $1.86 billion in FY2023 (+153.3%), $735.62 million in FY2022 (+104.4%) and $359.94 million in FY2021 (-12.7%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization since Q3 2024.
- Year-over-year, Market Capitalization increased in four of the last eight quarters, with growth averaging 72.8%.
- The fastest year-over-year change in Market Capitalization over five years came in Q2 2023 (growth of 631.6%), and the weakest in Q1 2025 (a decline of 70.0%).
- Business Quant data shows VKTX's Market Capitalization at $3.77 billion (Q1 2026), $4.04 billion (Q4 2025) and $2.96 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn |
| 10 | Viking Therapeutics | 3.08 Bn | 559.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.55 Bn |
| Mar 31, 2026 | 3.77 Bn |
| Dec 31, 2025 | 4.04 Bn |
| Sep 30, 2025 | 2.96 Bn |
| Jun 30, 2025 | 2.98 Bn |
| Mar 31, 2025 | 2.71 Bn |
| Dec 31, 2024 | 4.49 Bn |
| Sep 30, 2024 | 7.05 Bn |
| Jun 30, 2024 | 5.87 Bn |
| Mar 31, 2024 | 9.04 Bn |
| Dec 31, 2023 | 1.86 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.62 Bn |
| Mar 31, 2023 | 1.32 Bn |
| Dec 31, 2022 | 735.62 Mn |
| Sep 30, 2022 | 208.59 Mn |
| Jun 30, 2022 | 221.63 Mn |
| Mar 31, 2022 | 232.12 Mn |
| Dec 31, 2021 | 359.94 Mn |
| Sep 30, 2021 | 491.32 Mn |
API Access
Viking Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();